Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience. J Surg Oncol 1990 Jul;44(3):157-65
Date
07/01/1990Pubmed ID
2370799DOI
10.1002/jso.2930440307Scopus ID
2-s2.0-0025346408 (requires institutional sign-in at Scopus site) 14 CitationsAbstract
A retrospective analysis was conducted on 307 patients referred for radiation therapy at The University of Chicago and Michael Reese Hospital between 1971 and 1986. Median follow-up was 6.4 years. Treatment techniques varied during the time of the study. Actuarial disease-free survivals were 78%, 64%, 55%, 33%, 41%, and 60% for stage IB, IIA, IIB, IIIA, IIIB, and IVA, respectively. Stage, size of the cervical lesion, and hemoglobin level during treatment were prognostic factors. Treatment technique as well as time dose factors were analyzed with respect to survival, failures, and complications.
Author List
Rader JS, Haraf DJ, Halpern HJ, Rotmensch J, Spelbring DR, Sutton H, Javaheri G, Weichselbaum RRAuthor
Janet Sue Rader MD Chair, Professor in the Obstetrics and Gynecology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultCombined Modality Therapy
Female
Follow-Up Studies
Hemoglobins
Humans
Hysterectomy
Incidence
Middle Aged
Neoplasm Staging
Radiation Injuries
Radiotherapy Dosage
Recurrence
Retrospective Studies
Survival Rate
Uterine Cervical Neoplasms
